drugset / Trial / NCT00497783

Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)

NCT00497783 ↗

Phase 4 Completed 30 enrolled Sanofi
NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.

Timeline

Start
2007-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject lactoserum Unknown — —

Indications

No indication recorded.